516 Peripheral and tumoral immune activity in the expansion part of the first-in-human DuoBody®-PD-L1×4–1BB (GEN1046) trial

Overview of attention for article published in Journal for Immunotherapy of Cancer, November 2021

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (73rd percentile)
Above-average Attention Score compared to outputs of the same age and source (62nd percentile)

Mentioned by

patent: 3 patents

Readers on

mendeley: 3 Mendeley

So far, Altmetric has seen 3 patents that reference this research output.

Binding agents binding to PD-L1 and CD137 and use thereof

Grant US-12637515-B2

United States of America

Binding agents binding to PD-L1 and CD137 and use thereof

Grant US-12570751-B2

United States of America

MULTISPECIFIC BINDING AGENTS AGAINST PD-L1 AND CD137 IN COMBINATION WITH ANTI PD-1…

Application WO-2023057535-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity.